VanEck Pharmaceutical ETF
PPH
PPH
51 hedge funds and large institutions have $188M invested in VanEck Pharmaceutical ETF in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding
Funds holding: 48 → 51 (+3)
97% less call options, than puts
Call options by funds: $1.12M | Put options by funds: $41.8M
Holders
51
Holding in Top 10
–
Calls
$1.12M
Puts
$41.8M
Top Buyers
| 1 | +$84.7M | |
| 2 | +$34.2M | |
| 3 | +$13.8M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.86M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.7M |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$22M | |
| 3 | -$2.76M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$825K |
| 5 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
-$288K |